Compounding Questions Persist As Industry Enters Implementation Phase

FDA quality standards for facilities registering in a new category of outsourcing facilities, issues surrounding office-use compounding and what will happen if compounding firms do not register are key questions heading into 2014, according to observers of the evolving drug compounding industry.

subscription required at Insidehealthpolicy.com